First-in-Human Study of IL15–Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia

06 Apr 20264 min read0 viewsJournal Feed

GIST

Journal of Clinical Oncology, Volume 44, Issue 14 , Page 1323-1336, May 2026.

Clinical Editorial

Summary

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 06 Apr 2026. The item focuses on First-in-Human Study of IL15–Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia. Open the detail page to review the full original feed content.